Breast References

This page lists publications that have been referenced by our Specialists during a session.

_____________________

1)  A Positive Margin is Not Always an Indication For Radiotherapy After Mastectomy in Early Breast Cancer. Truong, PT, Olivott, IA, Speers, CH, et al. International Journal of Radiation Oncology Biology Physics.  2004;58(3): 797-804.

2) Accelerated Partial Breast Irradiation Consensus Statement From the American Society for Radiation Oncology (ASTRO). Smith, BD, Arthur, DW, Buchholz, TA, et al. International Journal of Radiation Oncology Biology Physics. 2009;74(4):987-1001.

3) Accelerated partial-breast irradiation using high-dose-rate interstitial brachytherapy: 12-year update of a prospective clinical study. Polgar C. Major T. Fodor J. Sulyok Z. Somogyi A. Lovey K. Nemeth G. Kasler M. Radiotherapy & Oncology. 2010; 94(3):274-9.

4) Adjuvant chemotherapy and radiotherapy in triple-negative breast carcinoma: a prospective randomized controlled multi-center trial. Wang J. Shi M. Ling R. Xia Y. Luo S. Fu X. Xiao F. Li J. Long X. Wang J. Hou Z. Chen Y. Zhou B. Xu M. Radiotherapy & Oncology. 2011; 100(2):200-4.

5) Age, Breast Cancer Subtype Approximation, and Local Recurrence After Breast-Conserving Therapy. Arvold, ND, Taghian, AG, Niemierko, A, et al. Journal of Clinical Oncology. 2011; 29(29):3885-3891.

6) Assessment of Coronary Heart Disease Morbidity and Mortality After Radiation Therapy for Early Breast Cancer . Katherine A. Vallis, Melania Pintilie, Nelson Chong, Eric Holowaty, Pamela S. Douglas, Peter Kirkbride, and Andreas Wielgosz. Journal of Clinical Oncology. 2002;20(4):1036-1042.

7) Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregionals Recurrence in Node-Negative, Estrogen Receptor-Positive Breast Cancer: Results From NSABP B-14 and NSABP B-20. Mamounas, EP, Tang, G, Fischer, B, et al. Journal of Clinical Oncology. 2010; 28(10):1677-1683.

8) Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Galimberti V. et al. Lancet Oncology. 2013; 14: 297-305.

9) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, McCall LM, Morrow M. JAMA. 2011;305(6):569-75.

10) Breast Cancer Radiotherapy and Coronary Artery Stenosis: Location, Location, Location. Timothy M. Zagar and Lawrence B. Marks. Journal of Clinical Oncology.2012;30(4): 350-352.

11) Breast Cancer Subtype Approximated by Estrogen Receptor, Progesterone Receptor, and Her-2 Is Associated With Local and Distant Recurrence After Breast-Conserving Therapy. Nguyen, PL, Taghian, AG, Katz, MS, et al. Journal of Clinical Oncology. 2008; 26(14):2373-2378.

12) Breast Cancer With Synchronous Metastases: Survival Impact of Exclusive Locoregional Radiotherapy . Romuald Le Scodan, Denise Stevens, Etienne Brain, Jean Louis Floiras, Christine Cohen-Solal, Brigitte De La Lande, Michelle Tubiana-Hulin, Sameh Yacoub, Maya Gutierrez, David Ali, Miriam Gardner, Patricia Moisson, Sylviane Villette, Florence Lerebours, Jean Nicolas Munck, and Alain Labib. Journal of Clinical Oncology. 2009; 27(9):1375-1381.

13) Cardiac Exposures in Breast Cancer Radiotherapy: 1950s – 1990s. Taylor, CW, et al. International Journal of Radiation Oncology Biology Physics. 2007; 69(5):1484-1495.

14) Cause-specific mortality in long-term survivors of breast cancer: A 25-year follow-up study. Maartje J. Hooning, Berthe M.P. Aleman, Agnes J.M. van Rosmalen, Marianne A. Kuenen, et al. International Journal of Radiation Oncology Biology Physics. 2006; 64(4):1081-1091.

15) Chest wall relapse after mastectomy for ductal carcinoma in situ: a report of 10 cases with a review of the literature.
Kim JH, Tavassoli F, Haffty BG. Cancer Journal. 2006 Mar-Apr;12(2):92-101.

16) Clinical Course of Breast Cancer Patients with Isolated Sternal and Full-Thickness Chest Wall Recurrences Treated With and Without Radical Surgery. Shen MC, Massarweh NN, Lari SA, Vaporciyan AA, Selber JC, Mittendorf EA, Macgregor MC, Smith BD, Kuerer HM. Annals of Surgical Oncology. 2013 Aug 20. [Epub ahead of print]

17) Clinical Impact of Delaying Initiation of Adjuvant Chemotherapy in Patients With Breast Cancer. de Melo Gagliato D1, Gonzalez-Angulo AM, Lei X, Theriault RL, Giordano SH, Valero V, Hortobagyi GN, Chavez-Macgregor M. Journal of Clinical Oncology. 2014 Jan 27. [Epub ahead of print]

17) Close or Positive Margins After Mastectomy For DCIS: Pattern Of Relapse And Potential Indications For  Radiotherapy. Rashtan, A, Iganej, S, Lui, IA, Natarajan, S. International Journal of Radiation Oncology Biology Physics. 2008; 72(4):1016-1020.

18) The complexity of breast cancer risk needs to be embraced, not oversimplified. Hughes, KS, Roche CA. Menopause. 2011; 18(6):599-600.

19) Cost Comparison of Radiation Treatment Options After Lumpectomy for Breast Cancer. Rachel A. Greenup MD, MPH, Melissa S. Camp MD, MPH, Alphonse G. Taghian MD, PhD, Julliette Buckley MD, Suzanne B. Coopey MD, Michele Gadd MD, Kevin Hughes MD, Michelle Specht MD, Barbara L. Smith MD, PhD . Annals of Surgical Oncology. 2012; 19(10): 3275-3281.

20) Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey. Taghian A. Mohiuddin M. Jagsi R. Goldberg S. Ceilley E. Powell S. Annals of Surgery. 2005; 241(4):629-39.

21) Determining Which Patients Require Irradiation of the Supraclavicular Nodal Area After Surgery for N1 Breast Cancer
Jeong Il Yu, Won Park, Seung Jae Huh, Doo Ho Choi, et al.  International Journal of Radiation Oncology Biology Physics. 2010; 78(4): 1135-1141.

22)  Development and Validation of a Heart Atlas to Study Cardiac Exposure to Radiation Following Treatment for Breast Cancer.  Feng, M, et al. International Journal of Radiation Oncology Biology Physics. 2011; 79(1):10-18.

23) Distribution of Coronary Artery Stenosis After Radiation for Breast Cancer. Greger Nilsson, Lars Holmberg, Hans Garmo, Olov Duvernoy, Iwar Sjo¨gren, Bo Lagerqvist, and Carl Blomqvist. Journal of Clinical Oncology. 2012;30(4): 380-86.

24) Effect of addition of adjuvant paclitaxel on radiotherapy delivery and locoregional control of node-positive breast cancer: cancer and leukemia group B 9344. Sartor CI. Peterson BL. Woolf S. Fitzgerald TJ. Laurie F. Turrisi AJ. Bogart J. Henderson IC. Norton L. Journal of Clinical Oncology. 2005; 23(1):30-40.

25) Effect of Radiotherapy After Breast-Conserving Surgery on 10-year Recurrence and 15-year Breast Cancer Death:  Meta-analysis of Individual Patient Data for 10801 Women in 17 Randomised Trials. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG).  Lancet. 2011: 378: 771-84.

26) Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study. H. Eidtmann, R. de Boer, N. Bundred, A. Llombart-Cussac, N. Davidson, P. Neven, G. von Minckwitz, J. Miller, N. Schenk, R. Coleman. Annals of Oncology. 2010; 21(11):2188-2194.

27) Estrogen Receptor, Progesterone Receptor, Her-2, and Response to Postmastectomy Radiotherapy in High-Risk Breast Cancer: The Danish Breast Cancer Cooperative Group. Kyndi, M, Sorensen, FB, Knudsen, H, et al. Journal of Clinical Oncology. 2008; 26(9):1419-1426.

28) The Feasibility and Accuracy of Sentinel Lymph Node Biopsy in Clinically Node-Negative Patients After Neoadjuvant Chemotherapy for Breast Cancer--a Systematic Review and Meta-Analysis. Tan VK, Goh BK, Fook-Chong S, Khin LW, Wong WK, Yong WS. Journal of Surgical Oncology. 2011;104(1):97-103.

29) First Results of the Randomised UK FAST Trial of Radiotherapy Hypofractionation for Treatment of Early Breast Cancer. The FAST Trialists Group. Radiotherapy and Oncology. 2011;100:93-100.

30)  Five-year outcome of patients classified using the American Society for Radiation Oncology consensus statement guidelines for the application of accelerated partial breast irradiation: an analysis of patients treated on the American Society of Breast Surgeons MammoSite Registry Trial. Shaitelman SF, Vicini FA, Beitsch P, Haffty B, Keisch M, Lyden M. Cancer. 2010; 116(20):4677-85.

31) Fractionation for Whole Breast Irradiation: An American Society for Radiation Oncology (ASTRO) Evidence-Based Guideline. Benjamin D. Smith, Soren M. Bentzen, Candace R. Correa, Carol A. Hahn, et al.  International Journal of Radiation Oncology Biology Physics. 2011; 81(1): 59-68.

32) Hypofractionated breast radiation: preferred standard of care? Bruce G Haffty, Thomas A Buchholz. The Lancet Oncology. 2013;14(11):1032 - 1034.

33) Hyopfractionated Whole-Breast Radiotherapy for Women With Early Breast Cancer: Myths and Realities. Yarnold, J, Bentsen, SM, Coles, C, et al. International Journal of Radiation Oncology Biology Physics.  2011; 79(1): 1-9.

34) The Impact of Age on Outcome in Early-Stage Breast Cancer. Beth M. Beadle, Wendy A. Woodward, Thomas A. Buchholz. Seminars in Radiation Oncology. 2011; 21(1): 26-34.

35) The Impact of the Size of Nodal Metastases on Recurrence Risk in Breast Cancer Patients With 1-3 Positive Axillary Nodes After Mastectomy. Eleanor E.R. Harris, Jessica Freilich, Hui-Yi Lin, Michael Chuong, et al. International Journal of Radiation Oncology Biology Physics. 2013; 85(3):609-614.

36) Implications of trial results: the potentially misleading notions of number needed to treat and average duration of life gained
Jacobus Lubsen.  Arno Hoes, Diederick Grobbee. The Lancet. 2000;356(9243):1757 - 1759.

37) Improved Methodology for Analyzing Local and Distant Recurrence. Gelman, R, Gelber, R, Henderson IC, et al. Journal of Clinical Oncology. 1990; 8(3):548-555.

38) Incidence of Breast Cancer With Distant Involvement Among Women in the United States, 1976 to 2009. Rebecca H. Johnson, MD; Franklin L. Chien, BA; Archie Bleyer, MD. JAMA. 2013;309(8):800-805

39) Increased Risk of Locoregional Recurrence for Women with T1-2N0 Triple-Negative Breast Cancer Treated
with Modified Radical Mastectomy Without Adjuvant Radiation Therapy Compared with Breast Conserving Therapy. Abdulkarim,  Cuartero J,  Hanson J, et al. Journal of Clinical Oncology. 2011; 29:2852-2858.

40) Increased use of regional radiotherapy is associated with improved outcome in a population-based cohort of women with breast cancer with 1–3 positive nodes. Elaine S. Wai, Mary Lesperance, Caroline H. Speers, Pauline T. Truong, et al. Radiotherapy and Oncology. 2010; 97(2):301-306.

41) Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: is further therapy warranted? Fitzsullivan E; Lari SA; Smith B; Caudle AS; Krishnamurthy S; Lucci A; Mittendorf EA; Babiera GV; Black DM; Wagner JL; Bedrosian I; Woodward W; Gainer SM; Hwang R; Meric-Bernstam F; Hunt KK; Kuerer HM. Annals Of Surgical Oncology. 2013; 20 (13): 4103-12.

42) Influence of lymphatic invasion on locoregional recurrence following mastectomy: indication for postmastectomy radiotherapy for breast cancer patients with one to three positive nodes. Matsunuma R. Oguchi M. Fujikane T. Matsuura M. Sakai T. Kimura K. Morizono H. Iijima K. Izumori A. Miyagi Y. Nishimura S. Makita M. Gomi N. Horii R. Akiyama F. Iwase T. International Journal of Radiation Oncology, Biology, Physics. 2912; 83(3):845-52.

43) The Internal Mammary Lymphatic Glands. Stibbe, EP. Journal of Anatomy.  1918; Vol. LII (Third Ser. Vol. XIIL).

44) Interim Cosmetic and Toxicity Results From RAPID: A Randomized Trial of Accelerated Partial Breast Irradiation Using Three-Dimensional Conformal External Beam Radiation Therapy . Ivo A. Olivotto, Timothy J. Whelan, Sameer Parpia, Do-Hoon Kim, Tanya Berrang, Pauline T. Truong, Iwa Kong, Brandy Cochrane, Alan Nichol, Isabelle Roy, Isabelle Germain, Mohamed Akra, Melanie Reed, Anthony Fyles, Theresa Trotter, Francisco Perera, Wayne Beckham, Mark N. Levine, and Jim A. Julian. Journal of Clinical Oncology.2013; 31(32):4038-4045.

45)  Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons. Umberto Veronesi, Roberto Orecchia, Alberto Luini, Viviana Galimberti, Stefano Zurrida, Mattia Intra, Paolo Veronesi, Paolo Arnone, Maria Cristina Leonardi, Mario Ciocca. Breast Cancer Research and Treatment. 2010;124(1):141-151.

46) Involved anterior margins after breast conserving surgery: Is re-excision required? R. Mullen, E.J. Macaskill, A. Khalil, E. Elseedawy, D.C. Brown, A.C. Lee, C.A. Purdie, L.B. Jordan, A.M. Thompson. European Journal of Surgical Oncology. 2012; 38(4): 302-306.

47) Ischemic heart disease after breast cancer radiotherapy. Darby SC. Ewertz M. Hall P. New England Journal of Medicine. 2013; 368(26):2527.

48) Is Radiation Indicated In Patients With Ductal Carcinoma In Situ and Close Or Positive Mastectomy Margins? Chan, LW, Rabban, J, Hwang, ES, et al. International Journal of Radiation Oncology Biology Physics. 2011; 80(1):25-30, 2011.

49)  Late Cardiac Mortality and Morbidity in Early-Stage Breast Cancer Patients After Breast-Conservation Treatment.  Eleanor E.R. Harris, Candace Correa, Wei-Ting Hwang, Jessica Liao, Harold I. Litt, Victor A. Ferrari, and Lawrence J. Solin
Journal of Clinical Oncology. 2006; 24(25):4100-4106.

50) Local Excision Alone Without Irradiation for Ductal Carcinoma In Situ of the Breast: A Trial of the Eastern Cooperative Oncology Group . Lorie L. Hughes, Molin Wang, David L. Page, Robert Gray, Lawrence J. Solin, Nancy E. Davidson, Mary Ann Lowen, James N. Ingle, Abram Recht, and William C. Wood. Journal of Clinical Oncology. 2009; 27(32):5319-5324.

51) Local Recurrence of Ductal Carcinoma In Situ after Skin-Sparing Mastectomy. Carlson, GW, FACS, Page, A, Johnson, E, et al. Journal of the American College of Surgeons. 2007; 204(5):1074-1078.

52) Local Therapy and Survival in Breast Cancer. Punglia, RS, Morrow, M, Winer, EP, Harris, JR. New England Journal of Medicine. 2007; 356(23):2399- 2405.

53) Locoregional Failure 10 Years After Mastectomy and Adjuvant Chemotherapy With or Without Tamoxifen Without Irradiation: Experience of the Eastern Cooperative Oncology Group. Journal of Clinical Oncology.1999; 17(6):1689-1700.

54) Locoregional Treatment for Breast Carcinoma After Hodgkin's Lymphoma: The Breast Conservation Option. Sophie Haberer, Lisa Belin, Romuald Le Scodan, Youlia M. Kirova, et al.   International Journal of Radiation Oncology Biology Physics. 2012;82(2):e145-e152.

55) Locoregional Treatment Outcomes After Multimodality Management of Inflammatory Breast Cancer. Ian J. Bristol, Wendy A. Woodward, Eric A. Strom, Massimo Cristofanilli, et al. International Journal of Radiation Oncology Biology Physics. 2008;72(2):474-484.

56) Locoregional Recurrence Patterns After Mastectomy and Doxorubicin-Based Chemotherapy: Implications for
Postoperative Irradiation. Journal of Clinical Oncology. 2000;18(15):2817-2827.

57) Locoregional Recurrence Rates and Prognostic Factors for Failure in Node-Negative Patients Treated with Mastectomy: Implications for Postmastectomy Radiation. Jagsi, R, Phil., D., Raad, RA, Goldberg, S, et al. International Journal of Radiation Oncology Biology Physics.  2005; 62(4):1035-1039.

58) Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Christina Davies, Hongchao Pan, Jon Godwin, Prof Richard Gray, Prof Rodrigo Arriagada, Prof Vinod Raina, et al. The Lancet.  2013;381(9869):805-816.

59) Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Darby SC, McGale P, Taylor CW, Peto R. Lancet Oncology. 2005; 6(8):557-65.

60) Long-Term Outcomes in Breast Cancer Patients Undergoing Immediate 2-Stage Expander/Implant Reconstruction and Postmastectomy Radiation. Ho, A, Cordeiro, P, Disa, J, et al.  Cancer. 2012; 2552-2559.

61) Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer. Whelan, TJ, Pignol, J, Levine, MN, et al. New England Journal of Medicine. 2010; 362:513-520.

62) Low Locoregional Recurrence Rate Among Node-Negative Breast Cancer Patients With Tumors 5 cm or Larger Treated by Mastectomy, With or Without Adjuvant Systemic Therapy and Without Radiotherapy: Results From Five National Surgical Adjuvant Breast and Bowel Project Randomized Clinical Trials . Alphonse G. Taghian, Jong-Hyeon Jeong, Eleftherios P. Mamounas, David S. Parda, Melvin Deutsch, Joseph P. Costantino, and Norman Wolmark. Journal of Clinical Oncology. 2006; 24(24) :3927-3932.

63) Lumpectomy and Breast Irradiation for Breast Cancer Arising After Previous Radiotherapy for Hodgkin's Disease or Lymphoma. Deutsch, Melvin; Gerszten, Kristina; Bloomer, William D.; Avisar, Eli. American Journal of Clinical Oncology. 2001; 24(1):33-34.

64) Lumpectomy plus Tamoxifen with or without Irradiation in Women 70 Years of Age or Older with Early Breast Cancer Kevin S. Hughes, Lauren A. Schnaper, Donald Berry, Constance Cirrincione, Beryl McCormick, Judith Wheeler, et. al. for the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and Eastern Cooperative Oncology Group. New England Journal of Medicine. 2004; 351:971-977.

65) A Multicenter Randomized Trial of Breast Intensity-Modulated Radiation Therapy to Reduce Acute Radiation Dermatitis. Jean-Philippe Pignol, Ivo Olivotto, Eileen Rakovitch, Sandra Gardner, Katharina Sixel, Wayne Beckham, Thi Trinh Thuc Vu, Pauline Truong, Ida Ackerman, and Lawrence Paszat. Journal of Clinical Oncology. 2008; 26(13):2085-2092.

66) Multi-Institutional Review of Repeat Irradiation of Chest Wall and Breast for Recurrent Breast Cancer. Andrew O. Wahl, Alfred Rademaker, Krystyna D. Kiel, Ellen L. Jones, et al. International Journal of Radiation Oncology Biology Physics. 2008; 70 (2):477-484.

67) One decade later: trends and disparities in the application of post-mastectomy radiotherapy since the release of the American Society of Clinical Oncology clinical practice guidelines. Dragun AE. Huang B. Gupta S. Crew JB. Tucker TC. International Journal of Radiation Oncology, Biology, Physics. 2012; 83(5):e591-6.

68) Outcome at 8 Years After Breast-Conserving Surgery and Radiation Therapy for Invasive Breast Cancer: Influence of Margin Status and Systemic Therapy on Local Recurrence. Park, CC, Mitsumori, M, Nixon, A, Recht, A, et al. Journal of Clinical Oncology. 2000; 18:1668-1675. 

69) Patient subsets with T1-T2, node-negative breast cancer at high locoregional recurrence risk after mastectomy. Truong PT, Lesperance M, Culhaci A, et al. International Journal of Radiation Oncology Biology Physics. 2005;62:175–182.

70) Patterns and risk factors of locoregional recurrence in T1-T2 node negative breast cancer patients treated with mastectomy: implications for postmastectomy radiotherapy. Abi-Raad R, Boutrus R, Wang R, Niemierko A, Macdonald S, Smith B, Taghian AG. International Journal of Radiation Oncology Biology Physics. 2011;81(3):e151-7.

71) Patterns of Locoregional Failure in Patients With Operable Breast Cancer Treated by Mastectomy and Adjuvant Chemotherapy With or Without Tamoxifen and Without Radiotherapy: Results From Five National Surgical Adjuvant Breast and Bowel Project Randomized Clinical Trials. Alphonse Taghian, Jong-Hyeon Jeong, Eleftherios Mamounas, Stewart Anderson, John Bryant, Melvin Deutsch, and Norman Wolmark. Journal of Clinical Oncology. 2004;22(21):4247-4254.

72) Postpartum diagnosis demonstrates a high risk for metastasis and merits an expanded definition of pregnancy-associated breast cancer. Eryn B. Callihan, Dexiang Gao, Sonali Jindal, Traci R. Lyons, Elizabeth Manthey, Susan Edgerton, Alexander Urquhart, Pepper Schedin, Virginia F. Borges. Breast Cancer Research and Treatment. 2013; 138(2):549-559.

73) Prediction of Local Recurrence, Distant Metastases, and Death After Breast-Conserving Therapy in Early-Stage Invasive Breast Cancer Using a Five-Biomarker Panel.  Journal of Clinical Oncology. 2009; 27(28):4701-4708.

74) Predictors of Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From Combined Analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27 . Eleftherios P. Mamounas, Stewart J. Anderson, James J. Dignam, Harry D. Bear, Thomas B. Julian, Charles E. Geyer Jr, Alphonse Taghian, D. Lawrence Wickerham, and Norman Wolmark. Journal of Clinical Oncology. 2012; 30(32):3960-3966.

75) Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.
Rastogi P, Anderson SJ, Bear HD, Geyer CE, Kahlenberg MS, Robidoux A, Margolese RG, Hoehn JL, Vogel VG, Dakhil SR, Tamkus D, King KM, Pajon ER, Wright MJ, Robert J, Paik S, Mamounas EP, Wolmark N. Journal of Clinical Oncology. 2008;26(5):778-85.

76) Present-Day Locoregional Control in Patients with T1 or T2 Breast Cancer with 0 and 1 to 3 Positive Lymph Nodes After Mastectomy Without Radiotherapy. Ranjna Sharma, MD, Isabelle Bedrosian, MD, Anthony Lucci et al. Annals of Surgical Oncology .2010; 17:2899–2908.

77) Prospective Study of Wide Excision Alone for Ductal Carcinoma in Situ of the Breast . Julia S. Wong, Carolyn M. Kaelin, Susan L. Troyan, Michele A. Gadd, Rebecca Gelman, Susan C. Lester, Stuart J. Schnitt, Dennis C. Sgroi, Barbara J. Silver, Jay R. Harris, and Barbara L. Smith. Journal of Clinical Oncology. 2006; 24(7):1031-1036.

78) Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome.  Steve Heymann, Suzette Delaloge, Arslane Rahal, Olivier Caron, Thierry Frebourg, Lise Barreau, Corinne Pachet, Marie-Christine Mathieu, Hugo Marsiglia, Céline Bourgier. Radiation Oncology. 2010; 5:104-108.

79) Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer patients: Final analysis of the EORTC AMAROS trial (10981/22023).  Emiel J. Rutgers, Mila Donker, Marieke Evelien Straver, Philip Meijnen, Cornelis J. H. Van De Velde. Journal of Clinical Oncology. 2013; 31(suppl; abstr LBA1001).

80) Regional Recurrence in Breast Cancer Patients With Sentinel Node Micrometastases and Isolated Tumor Cells. Pepels, Manon J.; de Boer, Maaike; Bult, Peter; et al. Annals of Surgery. 2012; 255(1):116-121.

81) Re-surgery and chest wall re-irradiation for recurrent breast cancer - a second curative approach. Arndt-Christian Müller, Franziska Eckert, Vanessa Heinrich, Michael Bamberg, Sara Brucker,Thomas Hehr.  BMC Cancer. 2011;11:197.

82) Risk Factors for Locoregional Recurrence Among Breast Cancer Patients: Results From International Breast Cancer Study Group Trials I Through VII. A. Wallgren, M. Bonetti, R.D. Gelber, A. Goldhirsch, M. Castiglione-Gertsch, S.B. Holmberg, J. Lindtner, B. Thu¨rlimann, M. Fey, I.D. Werner, J.F. Forbes, K. Price, A.S. Coates, and J. Collins.  Journal of Clinical Oncology. 2003; 21(7): 1205-1213.

83) Risk of Cardiac Death After Adjuvant Radiotherapy for Breast Cancer. Sharon H. Giordano, Yong-Fang Kuo, Jean L. Freeman, Thomas A. Buchholz, Gabriel N. Hortobagyi, and James S. Goodwin. Journal of the National Cancer Institute. 2005; 97(6): 419-424.

84) Risk of Ischemic Heart Disease in Women after Radiotherapy  for Breast Cancer. Sarah C. Darby, Marianne Ewertz, Paul McGale, Anna M. Bennet, Ulla Blom-Goldman, Dorthe Brønnum, Candace Correa, David Cutter, et al. 
New England Journal of Medicine. 2013;368(11): 987-98.

85) Risk of Subclinical Micrometastatic Disease in the Supraclavicular Nodal Bed According to the Anatomic Distribution in Patients With Advanced Breast Cancer. Valerie K. Reed, Jose L. Cavalcanti, Eric A. Strom, George H. Perkins, et al. International Journal of Radiation Oncology Biology Physics. 2008; 71(2): 435-440.

86) Sequencing of Chemotherapy and Radiation Therapy in Early-Stage Breast Cancer: Updated Results of a Prospective Randomized Trial . Jennifer R. Bellon, Steven E. Come, Rebecca S. Gelman, I. Craig Henderson, Lawrence N. Shulman, Barbara J. Silver, Jay R. Harris, and Abram Recht. Journal of Clinical Oncology. 2005; 23(9):1934-1940.

87) Statement of the Science Concerning Locoregional Treatments After preoperative Chemotherapy for Breast Cancer: a National Cancer Institute Conference. Buchholz TA, Lehman CD, Harris JR, et al. Journal of Clinical  Oncology. 2008; 26:791-7.

88) Subsets of Women With Close or Positive Margins After Breast-Conserving Surgery With High Local Recurrence Risk Despite Breast Plus Boost Radiotherapy. Krystine Lupe, Pauline T. Truong, Cheryl Alexander, Mary Lesperance, et al. International Journal of Radiation Oncology Biology Physics. 2011; 81(4):e561-e568.

89) Surgical Margins and the Risk of Local-Regional Recurrence After Mastectomy Without Radiation Therapy.
Stephanie K. Childs,Yu-Hui Chen, Margaret M. Duggan, Mehra Golshan, Stephen Pochebit, Julia S. Wong, Jennifer R. Bellon. International Journal of Radiation Oncology Biology Physics. 2012; 84(5): 1133-1138.

90) Surgical Margins in Lumpectomy for Breast Cancer —Bigger Is Not Better. Monica Morrow, M.D., Jay R. Harris, M.D., and Stuart J. Schnitt, M.D. New England Journal of Medicine. 2012; 367(1):79 - 82.

91) Ten-Year Recurrence Rates in Young Women With Breast Cancer by Locoregional Treatment Approach. Beth M. Beadle, Wendy A. Woodward, Susan L. Tucker, Elesyia D. Outlaw, et al.  International Journal of Radiation Oncology Biology Physics. 2009;73(3): 734-744.

92) Ten-Year Survival Results of a Randomized Trial of Irradiation of Internal Mammary Nodes After Mastectomy. Christophe Hennequin, Nadine Bossard, Stéphanie Servagi-Vernat, Philippe Maingon, et al. International Journal of Radiation Oncology Biology Physics. 2013;86(5): 860-866.

93) The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Joanne S Haviland, J Roger Owen, Prof John A Dewar, Rajiv K Agrawal, Jane Barrett, Prof Peter J Barrett-Lee, H Jane Dobbs, Penelope Hopwood, Pat A Lawton, Brian J Magee, Judith Mills, Sandra Simmons, Mark A Sydenham, Karen Venables, et al. The Lancet Oncology. 2013;14(11):1086 - 1094.

94) Variability of the Depth of Supraclavicular and Axillary Lymph Nodes in Patients with Breast Cancer: Is a Posterior Axillary Boost Field Necessary? Bentel, GC, Marks, LB, Hardenbergh, PH, Prosnitz, LR. International Journal of Radiation Oncology Biology Physics. 2000;  47(3):755-758.

95) A Voluntary Breath-Hold Treatment Technique for the Left Breast With Unfavorable Cardiac Anatomy Using Surface Imaging. David P. Gierga, Julie C. Turcotte, Gregory C. Sharp, Daniel E. Sedlacek, et al. International Journal of Radiation Oncology Biology Physics. 2012;84(5): e663-e668.

96) Wedge Resection Margin Distances and Residual Adenocarcinoma in Lobectomy Specimens. Neal S. Goldstein, Monica Ferkowicz, Larry Kestin, Gary W. Chmielewski, and Robert J. Welsh. American Journal of Clinical Pathology. 2003; 120:720-724.